These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13891625)

  • 1. [On the behavior of 17-ketosteroids in prostate carcinoma before and after hormone therapy].
    FARINA L
    Endocrinol Sci Cost; 1961 Oct; 27():25-32. PubMed ID: 13891625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on the fractionation of urinary 17-ketosteroids in the field of urology. II. The fractionation of urinary 17-ketosteroids in the patients of prostatic cancer].
    MORIMOTO J
    Nihon Hinyokika Gakkai Zasshi; 1962 Jul; 53():516-30. PubMed ID: 14476073
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone excretion in prostatic cancer: the early and late effects of endocrine treatment on urinary oestrogens, 17-ketosteroids and 17-ketogenic steroids.
    BULBROOK RD; FRANKS LM; GREENWOOD FC
    Acta Endocrinol (Copenh); 1959 Aug; 31():481-99. PubMed ID: 13805840
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of cortisone and cortisol on 17-ketosteroid excretion in carcinoma of the prostate and other neoplasms.
    SOKAL JE; BUCHWALD KW
    Cancer; 1959; 12(1):183-6. PubMed ID: 13618868
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary steroid excretion and other biochemical indexes in prostatic cancer in relation to therapy.
    ACEVEDO H; LOBO-ONELL C; ZANARTU J
    Cancer; 1958; 11(5):1003-10. PubMed ID: 13585358
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of norethandrolone on 17-ketosteroid excretion in prostatic cancer patients.
    BRENDLER H; WINKLER BS
    J Clin Endocrinol Metab; 1959 Feb; 19(2):183-92. PubMed ID: 13620743
    [No Abstract]   [Full Text] [Related]  

  • 7. [STEROID HORMONE EXCRETION OF PATIENTS WITH DISEASES OF THE PROSTATE UNDER TREATMENT WITH NATURAL AND SYNTHETIC ESTROGENS].
    ZIMMERMANN W; BUESCHER HK; TAUPITZ A; THEWALT K
    Acta Endocrinol (Copenh); 1964; 45():SUPPL90:211-25. PubMed ID: 14111328
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of steroid preparations on chromatographic fractionation of 17-ketosteroids in patients with prostatic carcinoma].
    Frugoni A; Chianta A
    Minerva Urol; 1968; 20(4):157-60. PubMed ID: 5752881
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic aspects & physiopathological findings in patients subjected to bilateral castration & adrenalectomy for cancer of the breast & prostate in advanced stage. I. Behavior of several urinary steroids, of circulating eosinophils & blood phosphatases.
    FESANI F; PERACCHIA A; VISCONTI W
    Chir Ital; 1958 Feb; 10(1):16-29. PubMed ID: 13537250
    [No Abstract]   [Full Text] [Related]  

  • 10. The conversion of cortisone to 17-ketosteroids in patients with carcinoma of the prostate and of the lung.
    SLAUNWHITE WR; LIST B; SOKAL JE
    J Lab Clin Med; 1959 May; 53(5):737-42. PubMed ID: 13654915
    [No Abstract]   [Full Text] [Related]  

  • 11. [BIOCHEMICAL CHANGES IN THE BLOOD AND URINE IN PATIENTS WITH CANCER OF THE PROSTATE].
    VIKTOROV I; PATRASHKOV T
    Urol Mosc; 1963; 28():27-9. PubMed ID: 14084919
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in urine levels of neutral 17-ketosteroids and phenol ketosteroids in rabbits with functional disorders of the prostate gland].
    Sherstniuk RM
    Probl Endokrinol (Mosk); 1970; 16(4):95-9. PubMed ID: 5517123
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate.
    Geller J; Fruchtman B; Meyer C; Newman H
    J Clin Endocrinol Metab; 1967 Apr; 27(4):556-60. PubMed ID: 4164338
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endocrinological study on prostatic carcinoma: anti-androgenic therapy and extragonadal androgens (analysis of 17-ketosteroid fractions by gas-liquid chromatography].
    Ishibashi H
    Nihon Hinyokika Gakkai Zasshi; 1968 May; 59(5):351-73. PubMed ID: 4302504
    [No Abstract]   [Full Text] [Related]  

  • 15. [DETERMINATION OF URINARY 17-KETOSTEROID LEVELS IN THE DIAGNOSIS OF PROSTATE CARCINOMA].
    HAHN M; PAVLIK F
    Cas Lek Cesk; 1963 Jul; 102():772-5. PubMed ID: 14068693
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of the carcinoma of the prostate with gestagens (author's transl)].
    Popelier G
    Urologe A; 1973 May; 12(3):134-9. PubMed ID: 4127418
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of orchidectomy on the excretion of testosterone, 17-ketosteroids, estrogens, pregnanediol, 17-hydroxycorticosteroids and gonadotropins in urine].
    Klosterhalfen H; Voigt KD; Tamm J
    Urol Int; 1965; 20(6):364-75. PubMed ID: 5873139
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the 17-ketosteroid excretion during roentgen therapy of patients with genital carcinoma; statements on the prognostic value of 17-ketosteroids].
    NYIRI I; KOSTYA K
    Zentralbl Gynakol; 1957 Oct; 79(43):1677-84. PubMed ID: 13531775
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of the prostate cancer with 17-beta-ketosteroids].
    FUCHS HK
    Arztl Wochensch; 1953 Apr; 8(14):333-6. PubMed ID: 13065210
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sex hormone balance in prostate cancer].
    Kisliakova ND; Luntovskaia VA; Polianichko MF; Volovel'skiĭ IZ
    Vopr Onkol; 1978; 24(1):86-9. PubMed ID: 147568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.